Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Pacira BioSciences, Inc. (PCRX) had Income from Continuous Operations of $7.03M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$726.41M |
|
$7.03M |
|
$149.75M |
|
$576.66M |
|
$707.22M |
|
$19.19M |
|
$-2.32M |
|
$16.87M |
|
$16.87M |
|
$7.03M |
|
|
Income from Continuous Operations |
$7.03M |
$7.03M |
|
$7.03M |
|
$19.19M |
|
$108.28M |
|
44.57M |
|
45.04M |
|
$0.16 |
|
$0.16 |
|
| Balance Sheet Financials | |
$547.97M |
|
$140.69M |
|
$716.94M |
|
$1.26B |
|
$120.59M |
|
$372.19M |
|
$451.22M |
|
$571.81M |
|
$693.11M |
|
$304.80M |
|
$693.11M |
|
41.12M |
|
| Cash Flow Statement Financials | |
$151.99M |
|
$99.48M |
|
$-369.63M |
|
$276.77M |
|
$158.54M |
|
$-118.23M |
|
$57.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.54 |
|
-- |
|
-- |
|
0.35 |
|
0.54 |
|
79.39% |
|
2.64% |
|
2.64% |
|
14.91% |
|
2.32% |
|
0.97% |
|
$136.66M |
|
-- |
|
-- |
|
-- |
|
0.57 |
|
0.98 |
|
5.85 |
|
62.34 |
|
1.01% |
|
2.31% |
|
0.56% |
|
0.66% |
|
$16.86 |
|
$3.03 |
|
$3.37 |
|